Biotechnology Reagents & Kits Market to reach USD 1441.03 billion by 2032 at a CAGR of 11.04%
The biotechnology reagents and kits market is expanding rapidly. Major factors are advancements in molecular biology, personalized medicine, and automation. A 2023 study in Nature Biotechnology highlights that integrating artificial intelligence (AI) in laboratories has boosted operational efficiency by 60%, substantially reducing experimental timelines. Companies like Insilico Medicine have successfully applied AI to drug discovery, cutting research and development costs by up to 50% and accelerating the delivery of innovative solutions.